top of page

Search Results

Search results for "Glaxo Inc"

Results found for "Glaxo Inc"

  • đź“° GPCR Weekly News, May 27 to June 2, 2024

    This week's highlight includes congrats to: InĂŞs Pinheiro, for her Dr.

  • Canonical chemokine receptors as scavenging “decoys”

    mimicking inflammation, CCR1, CCR2, and CCR5 switch purely to scavenging (D'Amico G. et al. 2000), becoming incapable

  • đź“° GPCR Weekly News, May 20 to 26, 2024

    This week's highlight includes congrats to: Cam Sinh Lu, for his first Dr.

  • Adhesion GPCR Consortium Newsletter - May 2024

    deal for many, but in this new era of making sure that historically excluded demographics are finally included

  • Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery

    Once activated, ERKs translocate to the nucleus, phosphorylating various transcription factors, including In various pathological conditions, including cancer, aberrant ERK activity can lead to uncontrolled These include infrared fluorescence, electrochemiluminescence, fluorescence emission, immunofluorescence

  • đź“° GPCR Weekly News, May 13 to 19, 2024

    This week's highlight includes congrats to: John Teye Azietaku for his first contributor article on Illuminating Access recorded material from previous events, including the Dr. GPCR Summit editions.

  • Dynamic GPCR activation revealed through time-resolved Cryo-EM

    This interaction significantly increases the receptor’s affinity for GTP, allowing a detailed observation Further changes include the movement of Switch II towards the nucleotide-binding pocket and the stabilization

  • Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling

    protein-coupled receptors (GPCRs) are integral membrane proteins crucial for sensing extracellular signals, including comprising subfamilies such as Gs, Gi/o, Gq/11, and G12/13, which orchestrate downstream signaling events, including These biosensors have facilitated the investigation of various aspects of GPCR signaling, including ligand Despite their immense potential, utilizing FRET and BRET sensors in GPCR research comes with challenges, including The ONE-GO biosensors, designed in a single vector, incorporate a G protein tagged with a YFP acceptor

  • đź“° GPCR Weekly News, April 22 to 28, 2024

    This week's highlight includes congrats to: André Nguyen Dietzsch, Simone Prömel, et al. for their work on the Dysfunction of the adhesion GPCR latrophilin 1 (ADGRL1/LPHN1) increases the risk of obesity Norton The workshop includes: Four x 2-hour Zoom sessions One-on-one meeting with Dr. Hoare Access to Dr. Adhesion GPCRs Dysfunction of the adhesion G protein-coupled receptor latrophilin 1 (ADGRL1/LPHN1) increases

  • đź“° GPCR Weekly News, April 15 to 21, 2024

    This week's highlight includes congrats to: Luca Franchini and Cesare Orlandi for their research on Deorphanization The workshop includes: Four x 2-hour Zoom sessions One-on-one meeting with Dr. Hoare Access to Dr.

  • đź“° GPCR Weekly News, April 8 to 14, 2024

    This week's highlight includes congrats to: Tessa de Vries, Graham Ladds, Antoinette MaassenVanDenBrink The workshop includes: Four x 2-hour Zoom sessions One-on-one meeting with Dr. Hoare Access to Dr. This is an excellent opportunity to network and increase your visibility on our platform. Let’s dive into the Classified GPCR News from April 8th to 14th, 2024 Adhesion GPCRs High incidence of

  • From DNA day to GPCR genomics

    for the development of genomics, a field of study that examines an organism's entire DNA or genome, including variation in GPCRs is extensive; databases like GPCRdb provide a large database of genetic variations (including

  • đź“° GPCR Weekly News, April 1 to 7, 2024

    This week's highlight includes congrats to: David A Cooper, David Minh, et al., for their research on The workshop includes: Four x 2-hour Zoom sessions One-on-one meeting with Dr. Hoare Access to Dr. This is an excellent opportunity to network and increase your visibility on our platform.

  • đź“° GPCR Weekly News, March 25 to March 31, 2024

    This week's highlight includes congrats to: Junyi Liang, Niña Caculitan, and Adam W Smith for their research The workshop includes: 4x 2 hours live Zoom sessions (45-50 minutes lecture + 1-hour Q&A) Thirty minutes GPCR Ecosystem perks, including our forums, private groups, and all Ecosystem members Extended early Continue to increase your knowledge of Pharmacology by joining this practical approach class today.

  • GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions

    agonists produce the maximal response and can differ in intrinsic efficacy; 2) partial agonists are incapable Those include the risk of unintended off-target effects, limited selectivity due to closely related receptor The ligand alters the balance of these conformations, increasing the prevalence of some infrequent ones

  • đź“° GPCR Weekly News, March 18 to 24, 2024

    This week's highlight includes congrats to: Drs. 

  • đź“° GPCR Weekly News, March 11 to 17, 2024

    This week's highlight includes congrats to: Makaía M Papasergi-Scott, Peter Gmeiner, Brian K Kobilka,

  • đź“° GPCR Weekly News, March 4 to 10, 2024

    This week's highlight includes congrats to Drs. Khaled Abd-Elrahman, Stephen Ferguson et al.

  • đź“° GPCR Weekly News, February 26 to March 3, 2024

    This week's highlight includes congrats to: Christina Katharina Kuhn, Drs. Biagon Officially Incorporated In The State Of Illinois Septerna divulges new TSHR antagonists for hyperthyroidism

  • An overview of the compartmentalized GPCR Signaling: Relevance and Implications

    context is crucial for understanding the diverse signaling outcomes mediated by different receptors including However, emerging evidence suggests that GPCRs also signal from intracellular membranes including endosomes thyroid-stimulating hormone receptor (TSHR) has been shown to regulate distinct cellular processes, including can be regulated by the kinetics of signaling and the spatial organization of signaling effectors, including

  • đź“° GPCR Weekly News, February 19 to 25, 2024

    This week's highlight includes congrats to: Johanna Lena Schön, and Dr. 

  • đź“° GPCR Weekly News, February 12 to 18, 2024

    This week's highlight includes congrats to Julia Gardner, Dr. Dylan Scott Eiger, Chloe Hicks,  Dr. Confirmed speakers include Drs. 

  • đź“° GPCR Weekly News, February 5 to 11, 2024

    This week's highlight includes congrats to: Drs. Confirmed speakers include Drs. 

  • đź“° GPCR Weekly News, January 22 to 28, 2024

    Look at our curated GPCR coverage for this week, which includes 10 GPCR papers, seven industry news, Confirmed speakers include Drs.

  • đź“° GPCR Weekly News, January 15 to 21, 2024

    Check out our curated GPCR coverage for this week, which includes 14 GPCR papers, four industry news, The cost is USD $299 and includes: Four live Zoom sessions (1 hour lecture + 30 mins Q&A each) A 30-minute

  • đź“° GPCR Weekly News, January 8 to 14, 2024

    The cost is $299 and includes: All 4 live Zoom sessions ( 4x 1 hour lecture + 30 mins Q&A) 30-minute GPCR Ecosystem contents and perks, including our forums, private groups, and all Ecosystem members Only

  • đź“° GPCR Weekly News, January 1 to 7, 2024

    The cost is $299 and includes: All 4 live Zoom sessions ( 4x 1 hour lecture + 30 mins Q&A) 30-minute GPCR Ecosystem contents and perks, including our forums, private groups, and all Ecosystem members Go

  • đź“° GPCR Weekly News, December 18 to 31, 2023

    The cost is $299 and includes: All 4 live Zoom sessions ( 4x 1 hour lecture + 30 mins Q&A) Complimentary GPCR Ecosystem contents and perks, including our forums, private groups, and all Ecosystem members Go

  • Chemokine receptor-targeted drug discovery: progress and challenges

    inflammatory, autoimmune and infectious diseases (Proudfoot 2002), and in recent years attention has increasingly The therapeutic approaches mainly include small molecule inhibitors, as well as monoclonal antibodies

  • đź“° GPCR Weekly News, December 11 to 17, 2023

    The cost is $299 and includes: All 4 live Zoom sessions ( 4x 1 hour lecture + 30 mins Q&A) Complementary GPCR Ecosystem contents and perks, including our forums, private groups, and all Ecosystem members Go generation of high-impact medicines Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including

bottom of page